Izvorni znanstveni članak
https://doi.org/10.1080/1331677X.2017.1311223
IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India
Ravi Kiran
Puni tekst: engleski pdf 1.541 Kb
str. 873-891
preuzimanja: 662
citiraj
APA 6th Edition
Kiran, R. (2017). IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India. Economic research - Ekonomska istraživanja, 30 (1), 873-891. https://doi.org/10.1080/1331677X.2017.1311223
MLA 8th Edition
Kiran, Ravi. "IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India." Economic research - Ekonomska istraživanja, vol. 30, br. 1, 2017, str. 873-891. https://doi.org/10.1080/1331677X.2017.1311223. Citirano 29.12.2024.
Chicago 17th Edition
Kiran, Ravi. "IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India." Economic research - Ekonomska istraživanja 30, br. 1 (2017): 873-891. https://doi.org/10.1080/1331677X.2017.1311223
Harvard
Kiran, R. (2017). 'IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India', Economic research - Ekonomska istraživanja, 30(1), str. 873-891. https://doi.org/10.1080/1331677X.2017.1311223
Vancouver
Kiran R. IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India. Economic research - Ekonomska istraživanja [Internet]. 2017 [pristupljeno 29.12.2024.];30(1):873-891. https://doi.org/10.1080/1331677X.2017.1311223
IEEE
R. Kiran, "IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India", Economic research - Ekonomska istraživanja, vol.30, br. 1, str. 873-891, 2017. [Online]. https://doi.org/10.1080/1331677X.2017.1311223
Sažetak
Different shades of World Trade Organization (WTO) agreement on
trade-related intellectual property rights (TRIPS) are reflected in
the Indian pharmaceutical industry, but small and medium-scale
pharmaceutical firms are slowly increasing their product innovation,
process innovation and research and development (R&D) intensity.
Analysis of variance results highlight a significant difference in
performance of sole proprietorship/partnership, private limited and
public limited firms vis-à-vis product innovation, process innovation,
increased range of goods and services, R&D intensity, new technology
adoption and adaptation. Factor analysis results indicated that
developing intellectual property rights (IPR), technological measures
and marketing practices explained 80.256% of variation. Policy
initiative factor is dominating and SMEs are still relying heavily on
support from government.
Ključne riječi
Trade-related intellectual property rights (TRIPS); intellectual property rights (IPRs); R&D intensity; small and medium enterprises (SMEs); pharmaceutical industry
Hrčak ID:
182575
URI
https://hrcak.srce.hr/182575
Datum izdavanja:
1.12.2017.
Posjeta: 1.228
*